Ellen Vogel O.T.

Recommended Articles

• Muscular Dystrophy: Telling a Child the Truth About His/Her Condition

  Muscular dystrophy is a category of muscle diseases that cause progressive weakness and loss of muscle mass.  Muscular dystrophy (MD) is either inherited or can be due to a genetic mutation. Kids with MD usually follow a normal pattern of growth development in the first few years of their lives,...

• Early Warning Signs of Multiple Sclerosis

  Is it Multiple Sclerosis?Although some of the symptoms of multiple sclerosis are common, there is no definitive pattern that applies to everyone. The symptoms of multiple sclerosis also resemble those of many other diseases. What sets the symptoms of MS apart from other conditions is time. In many...

• Targeting Enzyme May Be an Approach to Alzheimer’s Therapy

  Targeting particular enzymes to cure diseases or to relieve symptoms has never been an easy task. Indiscriminate targeting often results in unnecessary potentially toxic effects. For the same reasons, early attempts to target HDAC2 were not successful.Researchers knew that HDAC2 plays a vital role...

• Is Lactose Intolerance Preventable?

  The impaired ability to digest lactose is called lactose intolerance. Lactose is a sugar found in milk and dairy products. Digestion breaks lactose down into two simple sugars called lactase, which is an enzyme found in the small intestine. If there is an insufficient production of this enzyme,...

• What Is a Rotavirus Vaccine?

  A rotavirus is an oral vaccine against the rotavirus infection, which causes diarrhea, vomiting, fever, and headache in babies aged between 8-12 weeks. The diarrhea can be severe, which leads to dehydration. This vaccine is given to the child through the mouth using a dropper. Who should have a...

• New Treatment for Celiac Disease Using Nanoparticles Is Underway

  Recently, investigators have found a potential way to develop a treatment for celiac disease, which, according to Cour Pharmaceuticals focuses on the autoimmune disease, along with other inflammatory diseases. The treatment has been approved for clinical trials in August, 2017, and these trials have...